Dr Dippel reports funding from the Dutch Heart Foundation, Brain Foundation Netherlands, The Netherlands Organization for Health Research and Development, Health~Holland Top Sector Life Sciences & Health, and unrestricted grants from Penumbra Inc., Stryker, Medtronic, Thrombolytic Science, LLC and Cerenovus for research, all paid to the institution outside the submitted work
Cagrilintide is an investigational compound , and current knowledge continues to evolve as additional clinical trial data becomes available
Competing interests None declared
For the research context it is key for understanding why amylin analogs do not develop tolerance with chronic use (unlike many other anti-obesity molecules)
Vitamin B12 is essential for life
Laboratory verification THIRD-PARTY TESTED Independently analysed Every peptide is screened by an accredited independent laboratory